Population Pharmacokinetics of Cladribine in Patients with Multiple Sclerosis

被引：0
|
作者：
Radojka M. Savic
Ana M. Novakovic
Marianne Ekblom
Alain Munafo
Mats O. Karlsson
机构：
[1] University of California San Francisco,Department of Bioengineering and Therapeutic Sciences
[2] Uppsala University,Department of Pharmaceutical Biosciences
[3] Persson Ekblom Sarl,undefined
[4] Merck Institute for Pharmacometrics,undefined
来源：
Clinical Pharmacokinetics | 2017年 / 56卷
关键词：
Multiple Sclerosis; Cladribine; Visual Predictive Check; Oral Tablet; Absorption Delay;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1245 / 1253
页数：8
相关论文
共 50 条
  • [21] Cladribine in the treatment of relapsing multiple sclerosis
    Robles-Cedeno, Rene
    Ramio-Torrenta, Lluis
    REVISTA DE NEUROLOGIA, 2018, 67 (09) : 343 - 354
  • [22] Cladribine in aggressive forms of multiple sclerosis
    Martinez-Rodriguez, J. E.
    Cadavid, D.
    Wolansky, L. J.
    Pliner, L.
    Cook, S. D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 (06) : 686 - 689
  • [23] Cladribine in aggressive forms of multiple sclerosis
    Martinez-Rodriguez, J. E.
    Cadavid, D.
    Wolansky, L.
    Cook, S. D.
    MULTIPLE SCLEROSIS, 2006, 12 : S213 - S214
  • [24] Pregnancy outcomes with cladribine in multiple sclerosis
    Reactions Weekly, 2020, 1807 (1) : 9 - 9
  • [25] Treating multiple sclerosis with generic cladribine
    Alvarez-Gonzalez, C.
    Allen-Philbey, K.
    Mathews, J.
    Espasandin, M.
    Turner, B. P.
    Gnanapavan, S.
    Marta, M.
    Giovannoni, G.
    Baker, D.
    Schmierer, K.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 604 - 605
  • [26] CLADRIBINE TREATMENT OF MULTIPLE-SCLEROSIS
    REILLY, D
    LANCET, 1994, 344 (8921): : 537 - 537
  • [27] Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study
    Cook, S.
    Vermersch, P.
    Comi, G.
    Giovannoni, G.
    Rammohan, K.
    Rieckmann, P.
    Sorensen, P. Soelberg
    Hamlett, A.
    Miret, M.
    Weiner, J.
    Viglietta, V.
    Musch, B.
    Greenberg, S. J.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 (05) : 578 - 593
  • [28] Updated Safety Analysis of Cladribine Tablets in the Treatment of Patients with Multiple Sclerosis
    Cook, Stuart D.
    Giovannoni, Gavin
    Leist, Thomas P.
    Syed, Sana
    Nolting, Axel
    Damian, Doris
    Schick, Regina
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 54 - 55
  • [29] Clinical experience with Cladribine in Multiple Sclerosis Patients. A multicentre Study
    Meca-Lallana, V.
    Diaz Perez, C.
    Valero, G.
    Aguirre, C.
    Millan, J.
    Iniesta, F.
    del Rio, B.
    Vivancos, J.
    Meca-Lallana, J.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 94 - 94
  • [30] COVID-19 in cladribine-treated patients with multiple sclerosis
    Oreja-Guevara, C.
    Meca-Lallana, V.
    Brieva, L.
    Fernandez-Diaz, E.
    Garcia-Dominguez, J. M.
    Garcia-Estevez, D.
    Llorens, G.
    Moreno-Torres, I.
    Valenzuela, F. J.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 59 - 60
12345